According to Emergen Research’s current report, the global Interventional Oncology Devices Market is expected to be worth USD 3.11 billion by 2027. The global interventional oncology devices market is expected to proliferate due to the growing preference for minimally invasive treatments. The rise in government initiatives to support interventional oncology is expected to further fuel market growth. In addition, growing technical developments in devices are also expected to accelerate the growth of the industry.
A lack of professional oncologists and radiologists is expected to hinder market growth in the projected timeframe.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/387
Key Highlights From The Report
- In September 2020, Sirtex Medical Limited announced its strategic investment in Nanospectra Biosciences, Inc. The investment will provide funding to further develop AuroLase, Nanospectra’s leading prostate cancer tissue ablation technology, the first and only ultra-focal ablation procedure aimed at enhancing treatment quality, minimising anesthesia-related adverse effects, chemotherapy, and alternative focal therapies. This procedure uses the company’s proprietary AuroShells nanoparticle technique to minimise the harm of adjacent healthy tissue in order to kill solid cancer tumours.
- The embolization segment accounted for the largest market with a CAGR of 6.7 percent over the projected timeframe, as it is a minimally invasive therapy that provides benefits such as rapid recovery, can be practised and cost-effective by local anaesthesia.
- Bland embolization or transcatheter arterial embolization market share is expected to increase dramatically. This procedure is used for the treatment of liver tumours or for adjunctive treatment after surgery.
- During the projected period, the lung cancer segment would dominate the market because smoking practises have increased the incidences of lung cancer.
- North America is projected to dominate the market due to the growing prevalence of cancer, the easy availability of interventional oncology, and the rapid acceptance of technological advances due to substantial government spending on medical care.
- Key participants include Teleflex Incorporated, Sirtex Medical Limited, IMBiotechnologies Ltd., Boston Scientific Corporation, Merit Medical Systems, Inc., Interface Biomaterials B.V., BTG International Limited, IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.
Check Our Prices@ https://www.emergenresearch.com/select-license/387
Emergen Research has segmented the Global Interventional Oncology Devices Market on the basis of product type, process, cancer type, and region:
- Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Support
- Embolization
- Ablation
- Process Outlook (Revenue, USD Billion; 2017-2027)
- Non-Thermal Tumor Ablation
- Thermal Tumor Ablation
- Transcatheter Arterial Radioembolization
- Transcatheter Arterial Chemoembolization
- Bland Embolization or Transcatheter Arterial Embolization
- Cancer Type Outlook (Revenue, USD Billion; 2017-2027)
- Lung Cancer
- Liver Cancer
- Bone Cancer
- Breast Cancer
- Prostate Cancer
- Kidney Cancer
- Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/interventional-oncology-devices-market
- Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Rest of MEA
- North America
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
